A decade ago, the global community established the goal to end AIDS as a public health threat by 2030 through reducing new HIV infections and AIDS-related deaths by 90% from 2010 levels.1 Progress has ...

The program known as PEPFAR is one of the most effective and popular U.S. foreign aid projects in history, and the government ...

Despite the recent approval of lenacapavir as a twice yearly PrEP, there is still a need for choice in HIV prevention, argue ...

The administration made a deal with Senate Republicans to remove $400 million in proposed cuts to the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR).

ViiV Healthcare, the HIV-focused joint venture majority owned by GSK , said on Monday it has expanded its licensing deal with ...

The World Health Organization (WHO) released today new guidelines recommending the use of injectable lenacapavir (LEN) twice ...

The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention as a tool ...

U.S. funding cuts to AIDS programs could lead to millions of deaths, disrupting progress made against the disease.

A new U.N. AIDS agency report says the sudden withdrawal of U.S. funding has caused a "systemic shock" to the global effort ...

Some poorer nations hit by cuts in HIV/AIDS funding from rich donors have boosted their own spending in response, but not ...

Some Republican senators are interested in trimming the package of cuts to public broadcasting and global health programs.